Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: Cancer as a risk factor

被引：0

作者：

Otten, HMMB

Prins, MH

Smorenburg, SM

Hutten, BA

机构：

[1] Acad Med Ctr, Dept Internal Med, NL-1100 DD Amsterdam, Netherlands

[2] Acad Med Ctr, Dept Clin Epidemiol, NL-1100 DD Amsterdam, Netherlands

[3] Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands

来源：

HAEMOSTASIS | 2000年 / 30卷

关键词：

venous thromboembolism; cancer; chemotherapy; central venous catheterization; incidence of venous thromboembolism;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It is well documented that cancer patients undergoing surgery are at a sufficiently high risk of developing venous thromboembolism (VTE) to justify the routine use of prophylactic anticoagulant therapy, However, despite many studies showing an increased incidence of VTE associated with the use of chemotherapy in patients with breast carcinoma and with the use of indwelling venous access catheters in patients with various kinds of cancer, thromboprophylactic strategies are not yet widely used, Copyright (C) 2001 S. Karger AG. Basel.

引用

页码：72 / 76

页数：5

共 41 条

[11]

Falanga A, 1998, HAEMOSTASIS, V28, P50

[12] POSTOPERATIVE CHEMOTHERAPY AND TAMOXIFEN COMPARED WITH TAMOXIFEN ALONE IN THE TREATMENT OF POSITIVE-NODE BREAST-CANCER PATIENTS AGED 50 YEARS AND OLDER WITH TUMORS RESPONSIVE TO TAMOXIFEN - RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT-B-16 [J].

FISHER, B ;

REDMOND, C ;

LEGAULTPOISSON, S ;

DIMITROV, NV ;

BROWN, AM ;

WICKERHAM, DL ;

WOLMARK, N ;

MARGOLESE, RG ;

BOWMAN, D ;

GLASS, AG ;

KARDINAL, CG ;

ROBIDOUX, A ;

JOCHIMSEN, P ;

CRONIN, W ;

DEUTSCH, M ;

FISHER, ER ;

MYERS, DB ;

HOEHN, JL .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :1005-1018

[13] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

POISSON, R ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

WOLMARK, N ;

WICKERHAM, DL ;

FISHER, ER ;

MARGOLESE, R ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J ;

PATERSON, AHG ;

FELDMAN, MI ;

FARRAR, W ;

EVANS, J ;

LICKLEY, HL ;

KETNER, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484

[14] PULMONARY EMBOLI IN PATIENTS RECEIVING CHEMOTHERAPY FOR NON-HODGKINS LYMPHOMA [J].

GLENN, LD ;

ARMITAGE, JO ;

GOLDSMITH, JC ;

SORENSEN, S ;

HOWE, D ;

WEISENBERGER, DD .

CHEST, 1988, 94 (03) :589-594

[15]

GOODNOUGH LT, 1984, CANCER-AM CANCER SOC, V54, P1264, DOI 10.1002/1097-0142(19841001)54:7<1264::AID-CNCR2820540706>3.0.CO

[16]

2-R

[17] The prevalence and associated variables of deep venous thrombosis in patients with advanced cancer [J].

Johnson, MJ ;

Sproule, MW ;

Paul, J .

CLINICAL ONCOLOGY, 1999, 11 (02) :105-110

[18] EXTRINSIC-PATHWAY ACTIVATION IN CANCER WITH HIGH FACTOR VIIA AND TISSUE FACTOR [J].

KAKKAR, AK ;

DERUVO, N ;

CHINSWANGWATANAKUL, V ;

TEBBUTT, S ;

WILLIAMSON, RCN .

LANCET, 1995, 346 (8981) :1004-1005

[19] LOW-MOLECULAR-WEIGHT HEPARIN AND PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSIS [J].

KAKKAR, VV ;

DJAZAERI, B ;

FOK, J ;

FLETCHER, M ;

SCULLY, MF ;

WESTWICK, J .

BRITISH MEDICAL JOURNAL, 1982, 284 (6313) :375-380

[20] DOUBLE-BLIND RANDOMIZED TRIAL OF VERY-LOW-DOSE WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN STAGE-IV BREAST-CANCER [J].

LEVINE, M ;

HIRSH, J ;

GENT, M ;

ARNOLD, A ;

WARR, D ;

FALANGA, A ;

SAMOSH, M ;

BRAMWELL, V ;

PRITCHARD, KI ;

STEWART, D ;

GOODWIN, P .

LANCET, 1994, 343 (8902) :886-889

← 1 2 3 4 5 →